Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined BOTOX Injection vs Prostatic Parenchyma Alone in BPH
NCT07645456Phase 1Completed
- Sponsor
- Benha University
- Start
- Oct 2025
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
Phase 1, randomised trial of botulinum toxin type A in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Benha University. Primary endpoint: International Prostate Symptom Score at 6 months. Started Oct 2025; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT07645456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07645456.